Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer
Clinical trial NCT06836726 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06836726
- Sponsor
- University Health Network, Toronto
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-27
- Primary completion
- 2028-05-27
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.